JP2019504050A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504050A5
JP2019504050A5 JP2018534122A JP2018534122A JP2019504050A5 JP 2019504050 A5 JP2019504050 A5 JP 2019504050A5 JP 2018534122 A JP2018534122 A JP 2018534122A JP 2018534122 A JP2018534122 A JP 2018534122A JP 2019504050 A5 JP2019504050 A5 JP 2019504050A5
Authority
JP
Japan
Prior art keywords
membered
alkyl
independently
substituted
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018534122A
Other languages
English (en)
Japanese (ja)
Other versions
JP6943859B2 (ja
JP2019504050A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/066497 external-priority patent/WO2017116702A1/en
Publication of JP2019504050A publication Critical patent/JP2019504050A/ja
Publication of JP2019504050A5 publication Critical patent/JP2019504050A5/ja
Application granted granted Critical
Publication of JP6943859B2 publication Critical patent/JP6943859B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018534122A 2015-12-28 2016-12-14 駆虫性デプシペプチド化合物 Expired - Fee Related JP6943859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562272040P 2015-12-28 2015-12-28
US62/272,040 2015-12-28
PCT/US2016/066497 WO2017116702A1 (en) 2015-12-28 2016-12-14 Anthelmintic depsipeptide compounds

Publications (3)

Publication Number Publication Date
JP2019504050A JP2019504050A (ja) 2019-02-14
JP2019504050A5 true JP2019504050A5 (enExample) 2020-01-30
JP6943859B2 JP6943859B2 (ja) 2021-10-06

Family

ID=57868331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018534122A Expired - Fee Related JP6943859B2 (ja) 2015-12-28 2016-12-14 駆虫性デプシペプチド化合物

Country Status (23)

Country Link
US (3) US10344056B2 (enExample)
EP (1) EP3397638B1 (enExample)
JP (1) JP6943859B2 (enExample)
KR (2) KR20220003663A (enExample)
CN (1) CN108699052B (enExample)
AR (1) AR107249A1 (enExample)
AU (2) AU2016380868B2 (enExample)
BR (1) BR112018013369A2 (enExample)
CA (1) CA3009867C (enExample)
CL (1) CL2018001744A1 (enExample)
CO (1) CO2018006527A2 (enExample)
HK (1) HK1255391A1 (enExample)
HU (1) HUE065907T2 (enExample)
IL (1) IL260262B2 (enExample)
MX (1) MX2018007948A (enExample)
MY (1) MY194716A (enExample)
NZ (1) NZ743913A (enExample)
PH (1) PH12018501367B1 (enExample)
RU (2) RU2715556C2 (enExample)
SG (1) SG11201805368YA (enExample)
TW (1) TWI787165B (enExample)
UY (1) UY37050A (enExample)
WO (1) WO2017116702A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114891070A (zh) 2015-05-20 2022-08-12 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
KR20220003663A (ko) 2015-12-28 2022-01-10 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 뎁시펩티드 화합물
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
MX2019005628A (es) 2016-11-16 2019-12-18 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidos antihelminticos.
AU2018219273B2 (en) 2017-02-08 2023-08-17 Boehringer lngelheim Vetmedica GMBH In vivo model for parasitic worm infection and methods for evaluating antiparasitic compounds, including compounds active against canine heartworm
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
AU2018363696B2 (en) 2017-11-07 2023-09-14 Elanco Animal Health Gmbh Method for the synthesis of cyclic depsipeptides
BR112020010399A2 (pt) * 2017-11-29 2020-11-24 Zoetis Services Llc depsipeptídeos endoparasitários
EP3749096A1 (en) 2018-02-08 2020-12-16 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
EP3908330A1 (en) 2019-01-10 2021-11-17 Zoetis Services LLC Anthelmintic laboratory animal model for heartworm
BR112021018631A2 (pt) 2019-03-19 2021-11-23 Boehringer Ingelheim Animal Health Usa Inc Compostos anti-helmínticos de aza-benzotiofeno e aza-benzofurano
WO2021178834A1 (en) * 2020-03-06 2021-09-10 LifeMax Laboratories, Inc. Topical pharmaceutical formulations of a cyclic depsipeptide
WO2021242581A1 (en) 2020-05-29 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic heterocyclic compounds
WO2022140728A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animam Health Usa Inc. Parasiticidal collar comprising isoxazoline compounds
JP2025507585A (ja) 2022-02-17 2025-03-21 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 流体製品メーラーを提供する方法及びシステム
WO2025057117A1 (en) * 2023-09-15 2025-03-20 Animol Discovery, Inc. Antiparasitic cyclic depsipeptides
WO2025202940A2 (en) * 2024-03-27 2025-10-02 Animol Discovery, Inc. Antiparasitic cyclic depsipeptides

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
AU695021B2 (en) 1993-02-19 1998-08-06 Meiji Seika Kaisha Ltd. PF1022 derivative cyclic depsipeptide
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
US5646244A (en) 1993-09-06 1997-07-08 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
SE9303657D0 (sv) 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
IL123776A (en) * 1995-09-22 2002-09-12 Bayer Ag History of Cyclodepsipeptide 1022 PF
EP0953563B1 (en) 1996-10-07 2003-04-16 Fujisawa Pharmaceutical Co., Ltd. Process for producing depsipeptide derivatives and novel intermediates therefor
DE19713626A1 (de) 1997-04-02 1998-10-08 Bayer Ag Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung
CA2292698A1 (en) 1997-06-04 1998-12-10 Bayer Aktiengesellschaft Desoxycyclodepsipeptides and their use for combatting endoparasites
DE19811559A1 (de) 1998-03-17 1999-09-23 Bayer Ag Cyclooctadepsipeptide
DE19828043A1 (de) 1998-06-24 1999-12-30 Bayer Ag Ektoparasitizide Mittel
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19962145A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
DE19962147A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10104362A1 (de) 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
UY26592A1 (es) 2001-02-20 2001-09-28 Bayer Ag Agentes endoparasiticidas
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US20040236191A1 (en) 2003-05-19 2004-11-25 Poliska Steven A. System and method for identifying and labeling livestock products, and managing data associated with those products
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
ES2351972T3 (es) 2004-02-27 2011-02-14 Ic Services Procedimiento y set para la identificación de animales.
DE102004055316A1 (de) 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
US20060202835A1 (en) 2005-02-25 2006-09-14 Osborne Industries, Inc. Dual frequency identification device
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
DE102008030764A1 (de) 2008-06-28 2009-12-31 Bayer Animal Health Gmbh Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
DE102008031283A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
DE102008031284A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit der Giardiose
US20110262969A1 (en) 2008-12-16 2011-10-27 Achim Harder Method for producing optically active, cyclic depsipeptides comprising lactic acid and phenyl lactic and having 24 ring atoms, using fungus strains of rosellinia type, and further species of xylariaceae
KR101002530B1 (ko) 2009-02-18 2010-12-17 삼성에스디아이 주식회사 알에프아이디 통신 장치
JP5779787B2 (ja) 2009-12-11 2015-09-16 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 真菌株から由来の新規な２４員のシクロオクタデプシペプチドおよびその駆虫剤または内部寄生虫駆除剤としての使用
WO2012028556A1 (en) 2010-08-31 2012-03-08 Bayer Animal Health Gmbh Macrocyclic lactones and their use and their combinations with other active substances
WO2012065031A2 (en) 2010-11-11 2012-05-18 Mlp Technology Inc. Animal data management
US9848290B2 (en) 2011-03-10 2017-12-19 Aruba Networks, Inc. Location based computerized system and method thereof
MY175307A (en) 2011-12-21 2020-06-18 Bayer Ip Gmbh Preparations comprising amorphous emodepside
HUE042661T2 (hu) 2012-06-13 2019-07-29 Meiji Seika Pharma Co Ltd Új ciklusos depszipeptid származék és ezt tartalmazó kártevõirtó szer
US20140306005A1 (en) 2013-04-14 2014-10-16 Forever Yours, Inc. Method for Data Transport and Recovery of Dependent Creatures
CN114891070A (zh) 2015-05-20 2022-08-12 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
KR20220003663A (ko) 2015-12-28 2022-01-10 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 뎁시펩티드 화합물
MX2019005628A (es) 2016-11-16 2019-12-18 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidos antihelminticos.

Similar Documents

Publication Publication Date Title
JP2019504050A5 (enExample)
PH12021550310A1 (en) Novel sulfonamideurea compounds
HK1257569A1 (zh) 磺醯脲和相关化合物及其用途
RU2017144495A (ru) Противогельминтные депсипептидные соединения
PH12020551821A1 (en) Novel compounds
WO2020113213A3 (en) Cyclic pantetheine derivatives and uses thereof
IL275762B1 (en) Derivatives of phenyl-so2-nh-c(=o)-phenyl-piperazine-ch2-1,2-cyclohexane-bicyclo[1.1.1]pentane and pharmaceutical compositions comprising them
MY204171A (en) Novel sulfonamide carboxamide compounds
WO2016161361A4 (en) Compositions and methods of targeting mutant k-ras
JP2019509276A5 (enExample)
JP2016532715A5 (enExample)
JP2015504081A5 (enExample)
JP2017523169A5 (enExample)
RU2008134534A (ru) 3,5-ди(арилили гетероарил)изоксазолы и 1,2,4-оксадиазолы в качестве агонистов рецентора s1p1, иммунодепрессантных и противовоспалительных агентов
JP2017501237A5 (enExample)
JP2015514808A5 (enExample)
RU2012136451A (ru) Композиции и способы улучшения активности протеасомы
HRP20220899T1 (hr) Spojevi policikličkog karbamoilpiridona i njihova farmaceutska uporaba
RU2005110061A (ru) Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло(2,2,1)гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина
FI3546462T3 (fi) Uusi oksoisokinoliinijohdannainen
RU2014121205A (ru) Производные азолов
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
IL313466A (en) Inhibiting creb binding protein (cbp)
RU2435760C2 (ru) 1н-хиназолин-2,4-дионы
EA202192900A1 (ru) Модуляторы пути интегрированной реакции на стресс